Literature DB >> 16534423

Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China.

Li Jiang1, Bing Xia, Jin Li, Mei Ye, Wenjuan Yan, Changsheng Deng, Yijuan Ding, Hesheng Luo, Wei Hou, Qiu Zhao, Nanzhi Liu, Hongyu Ren, Xiaohua Hou, Hualin Xu.   

Abstract

BACKGROUND: Inflammatory bowel disease (IBD) had been uncommon in China until about 1990, but since then, it has been seen in the clinical setting more and more. The prevalence and phenotype of IBD in the Chinese population is not well known. The present study investigates the trend of prevalence in ulcerative colitis (UC) and Crohn's disease (CD) in Wuhan City, central China, and evaluates clinical features, extraintestinal manifestations, and the treatment of IBD in the last 14 years.
METHODS: Three hundred and eighty-nine patients with UC and 63 patients with CD were retrospectively collected from 5 central hospitals in Wuhan City, in which high-quality endoscopic and histological diagnoses were available from 1990 to 2003. UC and CD were diagnosed based on clinical, experimental, radiological, endoscopic, and histological examinations according to the internationally accepted Lennard-Jones criteria.
RESULTS: The trend toward prevalence of UC and CD increased between 1990 and 2003 in Wuhan City. There was no change in the sex and age distribution comparing 1990 to 1996 with 1997 to 2003 both in UC and CD. However, the number of individuals with higher education and a professional occupation during 1997 to 2003 was significantly higher than that during the period 1990 to 1996 in patients with UC (OR 2.1, 95% CI 1.27-3.35, P = 0.004; OR 2.2, 95% CI 1.31-3.61, P = 0.003). The mean age of patients with CD was significantly younger than that of UC at the time of diagnosis (32.6 +/- 12.5 vs. 42 +/- 14.5, P < 0.0001). The ratio of male to female patients was 1.53:1 in UC and 2.32:1 in CD, respectively. The mean duration of onset of the disease to diagnosis was 1.4 years in UC and 1.1 years in CD. The extra intestinal manifestations of UC and CD were 5.7% and 19%, respectively, and complications of UC and CD were 6.4% and 50.8%, respectively. Only 3% of UC patients required surgery, whereas 27% of CD patients underwent surgical procedures (P < 0.001).
CONCLUSION: The prevalence of IBD has increased in Wuhan City, central China, but is not as high as in Western countries. The disease in Wuhan City has often been associated with young adult professional males with a high level of education. The clinical presentation of UC was often mild and had few extra intestinal manifestations.

Entities:  

Mesh:

Year:  2006        PMID: 16534423     DOI: 10.1097/01.MIB.0000201098.26450.ae

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  50 in total

1.  Risk of ulcerative colitis-associated colorectal cancer in China: a multi-center retrospective study.

Authors:  Wei Gong; Nonghua Lv; Bangmao Wang; Ye Chen; Yinglong Huang; Wenshen Pan; Bo Jiang
Journal:  Dig Dis Sci       Date:  2011-09-22       Impact factor: 3.199

2.  Sacroiliitis is common in Crohn's disease patients with perianal or upper gastrointestinal involvement.

Authors:  Young Hwangbo; Hyo Jong Kim; Ji Seon Park; Kyung Nam Ryu; Nam Hoon Kim; Jaejun Shim; Jae Young Jang; Seok Ho Dong; Byung Ho Kim; Young Woon Chang; Rin Chang
Journal:  Gut Liver       Date:  2010-09-24       Impact factor: 4.519

3.  Efficacy of T2 in active Crohn's disease: a prospective study report.

Authors:  Jianan Ren; Qingsong Tao; Xinbo Wang; Zhiming Wang; Jieshou Li
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

4.  Role of major histocompatibility complex class I-related molecules A*A5.1 allele in ulcerative colitis in Chinese patients.

Authors:  Min Lü; Bing Xia; Liuqing Ge; Yi Li; Jie Zhao; Fan Chen; Feng Zhou; Xiaolian Zhang; Jinquan Tan
Journal:  Immunology       Date:  2008-11-07       Impact factor: 7.397

5.  Racial and ethnic differences in health care utilization and outcomes among ulcerative colitis patients in an integrated health-care organization.

Authors:  Dan Li; Bernadette Collins; Fernando S Velayos; Liyan Liu; James D Lewis; James E Allison; Nicole T Flowers; Susan Hutfless; Oren Abramson; Lisa J Herrinton
Journal:  Dig Dis Sci       Date:  2013-10-31       Impact factor: 3.199

6.  Disease characteristics of inflammatory bowel disease (IBD): findings from a tertiary care centre in South Asia.

Authors:  Duminda Subasinghe; N M M Nawarathna; Dharmabandhu Nandadeva Samarasekera
Journal:  J Gastrointest Surg       Date:  2011-06-28       Impact factor: 3.452

7.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

8.  Epidemiology and gene markers of ulcerative colitis in the Chinese.

Authors:  Jun Yun; Chang-Tai Xu; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

9.  Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients.

Authors:  Debottam Bandyopadhyay; Sanjay Bandyopadhyay; Parasar Ghosh; Abhishek De; Anupam Bhattacharya; G K Dhali; Kshaunish Das
Journal:  Indian J Gastroenterol       Date:  2015-11-28

10.  Prevalence of inflammatory bowel disease in two districts of Sri Lanka: a hospital based survey.

Authors:  Madunil A Niriella; Arjuna P De Silva; Asangi H G K Dayaratne; Madurangi H A D P Ariyasinghe; Metthanandha M N Navarathne; Ranjith S K Peiris; D Nandadeva Samarasekara; Raveendra L Satharasinghe; Sharman Rajindrajith; Anuradha S Dassanayake; A Rajitha Wickramasinghe; H Janaka de Silva
Journal:  BMC Gastroenterol       Date:  2010-03-19       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.